AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

Clinical trial NCT00321581 · COMPLETED

Trial details

NCT number: NCT00321581
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory or Recurrent Solid Tumors Acute Myelogenous Leukemia

Start date: 2006-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.